A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to ...

Conventional vaccine adjuvants primarily rely on molecular binding and biochemical stimulation to activate immune responses, ...

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

Corvus Pharmaceuticals, Inc. jumps 165% on Phase 1 soquelitinib atopic dermatitis data; learn key efficacy, funding, and ...

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to ...

Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

Training people to activate a part of the brain linked to reward and positive expectations may be associated with an increase ...

The team’s research provides compelling evidence for the brain’s influence on physiology. A deeper understanding of this mind ...

In a major scientific breakthrough, researchers from Monash University and the Lions Eye Institute have discovered a tissue ...